Title: Pharmacokinetic/Pharmacodynamic Analysis of the BNC210 Attune Phase 2b Dataset Enables Dose Selection for Planned Phase 3 PTSD Study Presenter: Spyros Papapetropoulos, M.D., Ph.D., Neuphoria ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Operator: Good afternoon, and welcome to Oncolytics Biotech First Quarter Conference Call. All participants are in a listen-only mode.

Ph.D., MBA, Chief Executive Officer, Vir Biotechnology ... with confirmed partial responses in 33% (2/6) of participants with HER2-positive colorectal cancer (CRC). VIR-5500, the only dual ...

After San Francisco biotech company Third Harmonic Bio slashed ... and it’s working to set up a Phase 2 trial for later this year. Getting the prospect to “Phase 2 readiness” would make ...

two prestigious postdoctoral appointments, years of experience at a multinational biotech in Cambridge, and a stint at a biotech startup in the Boston suburbs. But when he was laid off in the summ ...

I believe that a good speculative biotech ... [In other words, it's rare for patients who don't smoke to get it, but can still get it]. It is important to note that there are two certain types ...

Expansion study to enroll patients in the U.S. and select countries in Europe and Asia Multiple milestones attainable for 2025 MAIA Biotechnology ... 101 pivotal Phase 2 trial in non-small ...

ISC or Class 12 students will appear for Economics and Biotechnology paper 1 (theory) exams today, February 21. The papers will begin at 2 pm and the duration will be three hours. The CISCE will ...

Jan. 30, 2025 (GLOBE NEWSWIRE) -- Portage Biotech, Inc. (“Portage” or the ... today announced that it has completed a private placement of $2.15 million from two Portage directors.

These factors explain why, despite the positive signs in Boston, biotech stocks performed poorly last year. Still, last year was appreciably better than the previous two, and a report released ...

The European Bioplastics Association reports that bioplastics production capacity increased to 2.18 million tons in 2023 and is anticipated ... processes employed in bioplastic production.